It took Walden’s in-depth surgical instrument experience and market knowledge to capture and communicate all of the dimensions of Millennium’s new approach to surgical instrument sales and marketing. You brought to the table the industry’s most sophisticated players and helped them appreciate our inside technical sales model focused on high margin specialty instruments using cutting edge data driven inbound marketing techniques.
We can’t thank you enough for every step of the process, culminating in a valuation higher than we expected and terrific reinvestment terms. We deeply appreciate the goodwill you engender with all bidders to break logjams, resolve issues and facilitate a win/win deal.
Our deal with Shore Capital was another great collaboration with the Walden team. We’ve now worked together on three transactions, sellside and buyside, over some ten years. There is a reason we keep coming back. It goes to the quality of your work, your integrity, your deep industry knowledge and your mature, “all in” approach. As always, you perfectly captured all the dimensions of our Silverlon woundcare technology, as if you were part of our company. It took special insight and vision to help us obtain multiple offers here and help our management, Board and shareholders analyze the fine points of each one. As you know, these deals have many pressure points and we admire your sense of humor and calm to smooth out the rough edges. We look forward to working with you again as we miss those early “Good Morning Viet Nam” calls.
Thanks for your support. I don’t think (no, I’m certain) the Visiometrics deal wouldn’t have happened without Walden’s efforts.
I was telling Todd yesterday that you were one of the most professional, sharp and enjoyable Investment Bankers with whom I’ve had the pleasure of working in my 30 years of doing this, and I’ve worked with tons of IBs over the years. You are a real pro with whom I look forward to the opportunity to work again!
Thank you so much for your expert guidance and involvement in all facets of the recent sale of our ophthalmic, micro-endoscopy business. We felt you melded so seamlessly with us that you were part of our company. Your rare skill set, combining extensive corporate law knowledge with decades of investment banking experience, was invaluable.
It took several years for ophthalmic surgeons to become comfortable utilizing our proprietary, triple-function endoscopy rather than an operating microscope for diagnostics and treatment. The endoscopic cyclophotocoagulation (ECP) procedure we pioneered was initially confused with more invasive procedures. We were so impressed with your understanding of these dynamics in presenting our company to prospective acquirers based on the science and safety/efficacy data, which demonstrated superior patient outcomes compared to other surgical techniques.
Your painstaking work mirrored ours, and we are delighted to now have our technology and products in the hands of Beaver-Visitec International. Their resources and commitment will surely facilitate further market penetration for the benefit of clinicians and patients. You understood that our systems represent a new and better standard of care that warranted far greater usage both domestically and internationally.
We especially want to thank you for your detailed negotiating skills, resulting in a doubling of the purchase price from the initial proposal and providing several options for increased consideration from future performance. Your “all in” approach, diligence, professionalism, and persistence were evident in every phase of the negotiating and sale process.